Core Laboratories (CLB) PT Lowered to $32 at Evercore ISI
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rises after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts CLB Hot Sheet
Price: $9.72 -0.51%
Rating Summary:
9 Buy, 13 Hold, 7 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 26 | New: 12
Rating Summary:
9 Buy, 13 Hold, 7 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 26 | New: 12
Join SI Premium – FREE
Evercore ISI analyst James West lowered the price target on Core Laboratories (NYSE: CLB) to $32.00 (from $34.00) while maintaining a In Line rating.
You May Also Be Interested In
- Insulet Corporation (PODD) PT Raised to $163 at TD Cowen
- United Therapeutics Corp. (UTHR) PT Raised to $720 at Raymond James
- Revvity Inc (RVTY) PT Raised to $177 at Stifel
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
